Trial Profile
A prospective, non-interventional multi-center observational study to evaluate the long-term effectiveness and safety of tocilizumab in patients with active rheumatoid arthritis in daily practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ICHIBAN
- Sponsors Roche
- 22 Nov 2021 Results (N=3164) assessing the safety and effectiveness of long-term tocilizumab treatment in elderly patients with rheumatoid arthritis (RA) and patients with age-associated comorbidities published in the Clinical and Experimental Rheumatology
- 09 Nov 2021 Results assessing the efficacy and safety of TCZ in subgroups according to BL concomitant GCs presented at the ACR Convergence 2021
- 05 Jun 2021 Status changed from active, no longer recruiting to completed, according to Results presented at the 22nd Annual Congress of the European League Against Rheumatism.